These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 27601382)

  • 21. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
    Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applicability of Xpert MTB/RIF assay for routine diagnosis of tuberculosis: a four-year single-center experience.
    Celik C; Gözel MG; Bakici MZ; Berk S; Ozşahin SL; Gültürk E
    Turk J Med Sci; 2015; 45(6):1329-34. PubMed ID: 26775391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pooling sputum from multiple individuals for Xpert® MTB/RIF testing: a strategy for screening high-risk populations.
    Zishiri V; Chihota V; McCarthy K; Charalambous S; Churchyard GJ; Hoffmann CJ
    Int J Tuberc Lung Dis; 2015 Jan; 19(1):87-90. PubMed ID: 25519796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing Pooled Sputum with Xpert MTB/RIF for Diagnosis of Pulmonary Tuberculosis To Increase Affordability in Low-Income Countries.
    Abdurrahman ST; Mbanaso O; Lawson L; Oladimeji O; Blakiston M; Obasanya J; Dacombe R; Adams ER; Emenyonu N; Sahu S; Creswell J; Cuevas LE
    J Clin Microbiol; 2015 Aug; 53(8):2502-8. PubMed ID: 26019204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular detection of Mycobacterium tuberculosis from sputum transported in PrimeStore(®) from rural settings.
    Daum LT; Peters RP; Fourie PB; Jonkman K; Worthy SA; Rodriguez JD; Ismail NA; Omar SV; Fischer GW
    Int J Tuberc Lung Dis; 2015 May; 19(5):552-7. PubMed ID: 25868023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pooling sputum samples to improve the feasibility of Xpert
    Ho J; Jelfs P; Nguyen PT; Sintchenko V; Fox GJ; Marks GB
    Int J Tuberc Lung Dis; 2017 May; 21(5):503-508. PubMed ID: 28399964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xpert MTB/Rif for the diagnosis of extrapulmonary tuberculosis--an experience from a tertiary care centre in South India.
    Suzana S; Ninan MM; Gowri M; Venkatesh K; Rupali P; Michael JS
    Trop Med Int Health; 2016 Mar; 21(3):385-92. PubMed ID: 26671654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Xpert® MTB/RIF assay evaluation in South Korea, a country with an intermediate tuberculosis burden.
    Kim SY; Kim H; Kim SY; Ra EK; Joo SI; Shin S; Seong MW; Yoo CG; Kim EC; Park SS
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1471-6. PubMed ID: 22981162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xpert MTB/RIF®, a novel automated polymerase chain reaction-based tool for the diagnosis of tuberculosis.
    Bowles EC; Freyée B; van Ingen J; Mulder B; Boeree MJ; van Soolingen D
    Int J Tuberc Lung Dis; 2011 Jul; 15(7):988-9. PubMed ID: 21682978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
    Tadesse M; Aragaw D; Dimah B; Efa F; Abebe G
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S48-S49. PubMed ID: 28043605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective testing for pulmonary tuberculosis using Xpert MTB/RIF assay for stool specimens in immunocompetent Pakistani children.
    Hasan Z; Arif F; Shakoor S; Mehnaz A; Akber A; Kanji A; Ashraf M; Hasan R
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S8-S9. PubMed ID: 28043630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of macroscopic sputum quality assessments to optimise sputum testing for tuberculosis.
    Ho J; Nguyen PT; Nguyen TA; Tran HK; Nguyen VS; Nhung NV; Hoa NB; Phong TN; Luu BK; Nguyen TM; Fox GJ; Marks GB
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):319-22. PubMed ID: 27046711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of GeneXpert MTB/RIF and conventional methods for the diagnosis of tuberculosis in Kosovo.
    Bajrami R; Mulliqi G; Kurti A; Lila G; Raka L
    J Infect Dev Ctries; 2016 Apr; 10(4):418-22. PubMed ID: 27131007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid molecular detection of pulmonary tuberculosis in HIV-infected patients in Santiago, Chile.
    Balcells ME; García P; Chanqueo L; Bahamondes L; Lasso M; Gallardo AM; Cifuentes L
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1349-53. PubMed ID: 22863872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of OMNIgene
    Zallet J; Olaru ID; Witt AK; Vock P; Kalsdorf B; Andres S; Hillemann D; Kranzer K
    Int J Tuberc Lung Dis; 2018 Aug; 22(8):945-949. PubMed ID: 29991406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introducing new tuberculosis diagnostics: the impact of Xpert(®) MTB/RIF testing on case notifications in Nepal.
    Creswell J; Rai B; Wali R; Sudrungrot S; Adhikari LM; Pant R; Pyakurel S; Uranw D; Codlin AJ
    Int J Tuberc Lung Dis; 2015 May; 19(5):545-51. PubMed ID: 25868022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of repeated NALC/NaOH- decontamination on the performance of Xpert MTB/RIF assay.
    Rachow A; Saathoff E; Mtafya B; Mapamba D; Mangu C; Rojas-Ponce G; Ntinginya NE; Boeree M; Heinrich N; Gillespie SH; Hoelscher M;
    Tuberculosis (Edinb); 2018 May; 110():56-58. PubMed ID: 29779774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial.
    Theron G; Zijenah L; Chanda D; Clowes P; Rachow A; Lesosky M; Bara W; Mungofa S; Pai M; Hoelscher M; Dowdy D; Pym A; Mwaba P; Mason P; Peter J; Dheda K;
    Lancet; 2014 Feb; 383(9915):424-35. PubMed ID: 24176144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.